We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

129 hedge funds and large institutions have $332M invested in Aerie Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $842K | Put options by funds: $211K

7% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 41

6% less funds holding

Funds holding: 137 → 129 (-8)

20% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 35

36% less capital invested

Capital invested by funds: $522M → $332M (-$190M)

Holders
129
Holders Change
-8
Holders Change %
-5.84%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
38
Reduced
41
Closed
35
Calls
$842K
Puts
$211K
Net Calls
+$631K
Net Calls Change
-$1.58M

Top Buyers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
+$24.9M
2
Morgan Stanley
Morgan Stanley
New York
+$19M
3
DM
Deerfield Management
New York
+$18M
4
Millennium Management
Millennium Management
New York
+$9.31M
5
CSS
Cubist Systematic Strategies
Connecticut
+$4.77M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$11.4M
2
William Blair Investment Management
William Blair Investment Management
Illinois
-$11.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$10.4M
4
ClearBridge Investments
ClearBridge Investments
New York
-$9.93M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCM
76
Graham Capital Management
Connecticut
$232K +$347K +33,168 New
CS
77
Credit Suisse
Switzerland
$205K -$135K -12,922 -31%
SEI Investments
78
SEI Investments
Pennsylvania
$201K -$16K -1,529 -5%
AQR Capital Management
79
AQR Capital Management
Connecticut
$173K +$258K +24,680 New
AIG
80
American International Group
New York
$158K -$7.05K -674 -3%
RA
81
Royce & Associates
New York
$157K – – –
CC
82
Centiva Capital
New York
$154K +$230K +21,936 New
Qube Research & Technologies (QRT)
83
Qube Research & Technologies (QRT)
United Kingdom
$153K +$228K +21,798 New
JP Morgan Chase
84
JP Morgan Chase
New York
$146K -$97.2K -9,293 -31%
Invesco
85
Invesco
Georgia
$137K -$17.1K -1,639 -8%
State Board of Administration of Florida Retirement System
86
State Board of Administration of Florida Retirement System
Florida
$137K +$1.57K +150 +0.8%
JMPWA
87
JP Morgan Private Wealth Advisors
California
$131K -$6.66K -636 -3%
Two Sigma Investments
88
Two Sigma Investments
New York
$129K +$192K +18,358 New
SSA
89
Schonfeld Strategic Advisors
New York
$126K +$187K +17,900 New
Rafferty Asset Management
90
Rafferty Asset Management
New York
$119K +$178K +17,021 New
VOYA Investment Management
91
VOYA Investment Management
Georgia
$118K -$1.93M -184,032 -92%
Legal & General Group
92
Legal & General Group
United Kingdom
$117K – – –
Verition Fund Management
93
Verition Fund Management
Connecticut
$116K +$173K +16,544 New
ONB
94
Old National Bancorp
Indiana
$115K -$5.26K -503 -3%
ProShare Advisors
95
ProShare Advisors
Maryland
$112K +$4.18K +400 +3%
Walleye Trading
96
Walleye Trading
New York
$110K -$193K -18,412 -54%
MIM
97
MetLife Investment Management
New Jersey
$107K – – –
AG
98
Algert Global
California
$107K -$34.6K -3,310 -18%
Royal Bank of Canada
99
Royal Bank of Canada
Ontario, Canada
$106K +$129K +12,286 +414%
T. Rowe Price Associates
100
T. Rowe Price Associates
Maryland
$94K -$164K -15,700 -54%
2 3
4
5 6

AERI Hedge Fund Activity: Q4 2021 in Review

129 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2021, worth a combined $332M — down 36% from $522M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of AERI and 28 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 38 added.

The largest buyer was Jefferies Group, opening a new position worth an estimated $24.9M. The largest seller was PFM Health Sciences, cutting an estimated $11.4M.

  • 129 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2021, down from 137 in Q3 2021.
  • Funds reported $332M of Aerie Pharmaceuticals stock for Q4 2021, down 36% quarter-over-quarter.
  • 28 funds opened new Aerie Pharmaceuticals positions in Q4 2021 and 35 closed out, a net change of -7 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2021 was Jefferies Group, an estimated $24.9M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2021 was PFM Health Sciences, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.